• No results found

Venous and arterial thrombosis : associations and risk factors Roshani, S.

N/A
N/A
Protected

Academic year: 2021

Share "Venous and arterial thrombosis : associations and risk factors Roshani, S."

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Venous and arterial thrombosis : associations and risk factors

Roshani, S.

Citation

Roshani, S. (2012, January 12). Venous and arterial thrombosis : associations and risk factors. Retrieved from https://hdl.handle.net/1887/18334

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/18334

Note: To cite this publication please use the final published version (if applicable).

(2)

Sara Roshani

Venous and arterial thrombosis,

Associations and risk factors

Op donderdag 12 januari 2012 om 15.00 uur in de Senaatskamer van het Academiegebouw, Rapenburg 73 te Leiden te Leiden Na afloop is er een receptie in het Academiegebouw Voor het bijwonen van de promotieplechtigheid wordt u verzocht zich aan te melden via aan te melden via

promotie.sara@gmail.com

Populierendreef 332 2272 HC Voorburg S.Roshani@lumc.nl paranimfen:

Renee de Mutsert

R.de _Mutsert@lumc.nl Arash Navabi

Arash Navabi

navabi@hotmail.com

Sara Roshani

Uitnodiging

Voor het bijwonen van de verdediging van het proefschrift

Venous and arterial thrombosis Associations and risk factors

V en ou s a nd ar ter ial thr om bo sis , a sso cia tio ns an d r isk s f ac tor s - S ara R osh an i

Referenties

GERELATEERDE DOCUMENTEN

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

We calculated the incidence of arterial cardiovascular complications (e.g. myocardial infarction, ischemic stroke, transient ischemic attack or peripheral arterial

In this study we aimed to evaluate the risk of recurrent venous thrombosis associated with plasma levels of the inflammatory markers, tumor necrosis factor (TNF)-a,

We compared the mean level of endogenous thrombin potential, antithrombin, protein C and S, Factor VIII and homocysteine as well as clot lysis time and thrombin activatable

A weakness is the retrospective design and that, despite its fairly large size, the number of double heterozygous or homozygous F5 R506Q and F2 G20210A carriers was

In chapter 8, inflammatory markers were studied as risk factors for recurrence of venous thrombosis, since several lines of evidence have indicated that inflammation promotes

Beste Iris Wicher en Michael Tanck, bedankt voor jullie snelle reacties op mijn e-mails en alle brainstorm sessies over de GENES studie.. Beste Danny Cohn, ik vond het bijzonder

The increased incidence of arterial thrombosis in individuals who have experienced venous thrombosis previously cannot be explained by the presence of established thrombophilic